Dr. Ashley Alex, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $716.39 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $345.08 | 10 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $124.99 | 1 | $0 (2022) |
| MDD US Operations, LLC | $89.41 | 5 | $0 (2024) |
| CSL Behring | $34.57 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $31.61 | 1 | $0 (2022) |
| Medtronic, Inc. | $26.13 | 1 | $0 (2021) |
| Merz Pharmaceuticals, LLC | $26.06 | 1 | $0 (2024) |
| PFIZER INC. | $19.84 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.70 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $161.23 | 7 | MDD US Operations, LLC ($53.37) |
| 2023 | $250.33 | 7 | AbbVie Inc. ($214.29) |
| 2022 | $233.44 | 5 | SANOFI-AVENTIS U.S. LLC ($124.99) |
| 2021 | $71.39 | 3 | AbbVie Inc. ($26.56) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: PAIN | ||||||
| 10/07/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: AMANTADINE | ||||||
| 06/20/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: Immunology | ||||||
| 05/09/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Musculoskeletal | ||||||
| 03/29/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: AMANTADINE | ||||||
| 01/24/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: AMANTADINE | ||||||
| 12/20/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2023 | MDD US Operations, LLC | GOCOVRI (Drug) | Food and Beverage | Cash or cash equivalent | $17.56 | General |
| Category: NEUROLOGY | ||||||
| 11/09/2023 | MDD US Operations, LLC | GOCOVRI (Drug) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: NEUROLOGY | ||||||
| 11/02/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/15/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/08/2022 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $31.61 | General |
| Category: Central Nervous System | ||||||
| 10/04/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/22/2022 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 06/09/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: HYPERHYDROSIS | ||||||
| 04/13/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2021 | Medtronic, Inc. | 3F (Device) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Heart Valves | ||||||
| 02/22/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 152 | 393 | $30,481 | $15,232 |
| 2022 | 6 | 103 | 186 | $20,276 | $10,713 |
| 2021 | 1 | 11 | 11 | $3,025 | $1,915 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 35 | $9,450 | $4,601 | 48.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 34 | $3,264 | $2,059 | 63.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 13 | 21 | $4,599 | $1,969 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 21 | $3,171 | $1,871 | 59.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 14 | 39 | $3,822 | $1,858 | 48.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $2,196 | $1,194 | 54.4% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 49 | $2,303 | $969.45 | 42.1% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 19 | 164 | $1,640 | $697.21 | 42.5% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 13 | 18 | $36.00 | $13.70 | 38.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 34 | 34 | $9,180 | $5,178 | 56.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 20 | $4,700 | $2,543 | 54.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 13 | 25 | $2,450 | $1,204 | 49.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 19 | $1,824 | $1,037 | 56.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 12 | 18 | $1,422 | $434.23 | 30.5% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2022 | 12 | 70 | $700.00 | $315.80 | 45.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $3,025 | $1,915 | 63.3% |
About Dr. Ashley Alex, M.D
Dr. Ashley Alex, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2016. The National Provider Identifier (NPI) number assigned to this provider is 1295198331.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashley Alex, M.D has received a total of $716.39 in payments from pharmaceutical and medical device companies, with $161.23 received in 2024. These payments were reported across 22 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($716.39).
As a Medicare-enrolled provider, Alex has provided services to 266 Medicare beneficiaries, totaling 590 services with total Medicare billing of $27,860. Data is available for 3 years (2021–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Neurology
- Location Williamsville, NY
- Active Since 04/04/2016
- Last Updated 09/20/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1295198331
Products in Payments
- BOTOX (Biological) $242.88
- UBRELVY (Drug) $75.70
- Gocovri (Drug) $53.37
- GOCOVRI (Drug) $36.04
- Hizentra (Biological) $34.57
- AJOVY (Biological) $31.61
- QULIPTA (Drug) $26.50
- 3F (Device) $26.13
- Xeomin (Biological) $26.06
- NURTEC ODT (Drug) $19.84
- STIOLTO RESPIMAT (Drug) $18.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Williamsville
Ryan Denhaese, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $2.7M
James Aitken
Student in an Organized Health Care Education/Training Program — Payments: $35,216
Jack Route, Dpm, DPM
Student in an Organized Health Care Education/Training Program — Payments: $16,044
Dr. Scott Sobieraj, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,279
Ndey Diallo, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,211
Scott Pollack, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $3,825